Research Triangle Park-based UVision360, which has created created a simplified, all-in-one hysteroscopy system to support the market shift to office based procedures, has raised new equity, according to a regulatory filing.
The UVision360hysteroscopy system provides the key elements that physicians desire for office-based procedures, at a price 4-5 times less than larger systems, with no software licenses or maintenance contracts.
Hysteroscopy as defined by the American College of Obstetricians and Gynecologists (ACOG) is: used to diagnose or treat problems of the uterus. A hysteroscope is a thin, lighted telescope-like device. It is inserted through the vagina into the uterus. The hysteroscope transmits the image of the uterus onto a screen. Other instruments are used along with the hysteroscope for treatment.
One of the most common uses for hysteroscopy is to find the cause of abnormal uterine bleeding.
Hysteroscopy also is used in the following situations:
· Remove adhesions that may occur because of infection from past surgery
· Examine the uterine cavity for potential causes of repeated miscarriage
· Locate and remove an intrauterine device
· Perform sterilization, in which the hysteroscope is used to place small implants into a woman’s fallopian tubes as a permanent form of birth control.
The company is located in the First Flight Venture Center off Davis Drive, RTP.
UVision360 received a Small Business Research Loan from the North Carolina Biotechnology Center in 2016 to help advance this important technology, which means all state taxpayers have a stake in UVision360’s success.
Read more at https://wraltechwire.com/rtp-startup-uvision-360-advances-in-startup-medtech-showdown/16612529/#VbZH8M0p0GzM2Hg2.99
According to a filing with the U.S. Securities and Exchange Commission, Uvision 360 has raised $307, 389 of a $750,000 equity offering. It raised $716, 427 of a $2 million equity offering in December 2016, and $110 in debt in June last year.
SEC filing
